SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
CNB Corporation (CNBZ) trades at a trailing P/E of 7.5. Trailing earnings yield is 13.39%. PEG 0.37 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (7.5); PEG ≤ 1.0 — Peter Lynch undervalued (0.37); earnings yield beats bond yields (13.39%).
- PEG Ratio 0.37 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 13.39% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
Overall SharesGrow Score: 62/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
17/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — CNBZ
Valuation Multiples
P/E (TTM)7.5
Forward P/EN/A
PEG Ratio0.37
Forward PEGN/A
P/B Ratio0.00
P/S Ratio1.31
EV/EBITDA0.0
Per Share Data
EPS (TTM)$3.18
Book Value / Share$0.00
Revenue / Share$18.13
FCF / Share$0.00
Yields & Fair Value
Earnings Yield13.39%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$1.37 |
$10.95M |
$1.66M |
15.1% |
| 2017 |
$1.08 |
$11.1M |
$1.31M |
11.8% |
| 2018 |
$-0.64 |
$12.14M |
$-779K |
-6.4% |
| 2019 |
$1.58 |
$13.44M |
$1.93M |
14.3% |
| 2020 |
$2.32 |
$16.03M |
$2.81M |
17.5% |
| 2021 |
$2.48 |
$16.04M |
$3M |
18.7% |
| 2022 |
$3.06 |
$16.82M |
$3.71M |
22.1% |
| 2023 |
$2.92 |
$16.28M |
$3.54M |
21.7% |
| 2024 |
$2.65 |
$17.37M |
$3.21M |
18.5% |
| 2025 |
$3.18 |
$21.96M |
$3.85M |
17.5% |
